A carregar...
Overview and Management of Dermatologic Events Associated with Targeted Therapies for Medullary Thyroid Cancer
Background: Treatment options for patients with advanced or metastatic medullary thyroid cancer (MTC) have, in recent years, expanded with the approval of two tyrosine kinase inhibitors (TKIs): vandetanib and cabozantinib. Other agents, including TKIs, are under clinical investigation for MTC. Altho...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Mary Ann Liebert, Inc.
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4148058/ https://ncbi.nlm.nih.gov/pubmed/24902006 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/thy.2013.0700 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|